Clinical Trial Update: Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a combination of docetaxel, carboplatin, trastuzumab, and lapatinib in early-stage breast cancer completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• DOCETAXEL (DOCETAXEL)
• Lapatinib (Lapatinib)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-03-22